A study to evaluate the safety and tolerability of AZD7442 in Healthy Chinese Adults

Trial Identifier:	D8850C00007
Sponsor:	AstraZeneca
NCTID::	NCT05437289
Start Date:	October 2021
Primary Completion Date:	November 2021
Study Completion Date:	January 2023
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Simplified Chinese (China)

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CN	Guangzhou, CN, 510515
CN	Nanchang, CN, 330006
CN	Shanghai, CN, 201107

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.